Literature DB >> 32006221

Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Jurgen Sota1, Donato Rigante2,3, Giacomo Emmi4, Giuseppe Lopalco5, Ida Orlando1, Gian Marco Tosi6, Bruno Frediani1, Antonio Vitale1, Silvana Guerriero7, Florenzo Iannone5, Lorenzo Vannozzi8, Claudia Fabiani6, Luca Cantarini9.   

Abstract

Behçet's syndrome (BS) is a multisystemic disorder displaying a marked variability across different geographic areas. The main aim of this study was to analyze demographic and clinical features of a cohort of BS patients diagnosed in three tertiary referral centers in Italy and detect potential associations between the different manifestations. Medical records of 396 patients (218 females, 178 males) were retrospectively analyzed. Mean age at onset was 30.00 ± 18.75 years with a female-to-male ratio of 1.22:1. Mucocutaneous features were the most frequent starting manifestations of BS, followed by eye inflammation. Erythema nodosum (p = 0.007), arthritis/arthralgias (p = 0.0115), and central nervous system (CNS) signs (p = 0.014) were significantly over-represented in female patients, whereas male gender was associated with lower mean age at onset (p = 0.031), higher frequency of pseudofollicular lesions, and uveitis (p = 0.00134 and p < 0.0001 respectively), particularly for posterior segment involvement and panuveitis (p < 0.0001). Regarding the association between disease features, genital ulcers were negatively associated with uveitis (p < 0.0001) and vascular involvement (p < 0.0001). Other negative associations were detected between uveitis and gastrointestinal involvement (p = 0.008), pseudofolliculitis and CNS signs (p = 0.031), vascular involvement (p = 0.002) and erythema nodosum (p = 0.013). Logistic regression identified male gender and genital ulcers, respectively, with a higher (OR 2.199 [1.397-3.461], p < 0.001) and lower risk (OR 0.157 [0.090-0.273], p < 0.0001) of developing major organ involvement. Our evaluations found that the disease had started mostly in the second and third decade with most severe features in the male gender, and that patients presenting with mucocutaneous manifestations were less prone to develop major organ involvement.

Entities:  

Keywords:  Behçet’s syndrome; Clinical features; Epidemiology; Italy

Mesh:

Year:  2020        PMID: 32006221     DOI: 10.1007/s11739-019-02248-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  44 in total

Review 1.  Behçet syndrome: is it one condition?

Authors:  H Yazici; S Ugurlu; E Seyahi
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Behçet's disease as an autoinflammatory disorder.

Authors:  Ahmet Gül
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-02

Review 3.  Behçet's disease as a systemic disease.

Authors:  M Cem Mat; Ayşegül Sevim; Izzet Fresko; Yalçın Tüzün
Journal:  Clin Dermatol       Date:  2013-11-23       Impact factor: 3.541

Review 4.  A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.

Authors:  Donato Rigante
Journal:  Expert Rev Clin Immunol       Date:  2017-02-01       Impact factor: 4.473

5.  Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Authors:  Claudia Fabiani; Antonio Vitale; Ida Orlando; Jurgen Sota; Marco Capozzoli; Rossella Franceschini; Mauro Galeazzi; Gian Marco Tosi; Bruno Frediani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2017-06-15       Impact factor: 3.397

Review 6.  One year in review 2018: Behçet's syndrome.

Authors:  Gulen Hatemi; Emire Seyahi; Izzet Fresko; Rosaria Talarico; Vedat Hamuryudan
Journal:  Clin Exp Rheumatol       Date:  2018-12-13       Impact factor: 4.473

Review 7.  Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.

Authors:  M Giza; D Koftori; L Chen; P Bowness
Journal:  Clin Exp Immunol       Date:  2017-10-06       Impact factor: 4.330

Review 8.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

9.  Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Authors:  Giacomo Emmi; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

Review 10.  Vascular Behçet's syndrome: an update.

Authors:  Giacomo Emmi; Alessandra Bettiol; Elena Silvestri; Gerardo Di Scala; Matteo Becatti; Claudia Fiorillo; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

View more
  6 in total

1.  The geographic and clinical clusters of Behçet's syndrome.

Authors:  Chiara Marvisi
Journal:  Intern Emerg Med       Date:  2020-03-29       Impact factor: 3.397

2.  Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.

Authors:  Jinjing Liu; Dong Yan; Zhimian Wang; Yunjiao Yang; Shangzhu Zhang; Di Wu; Lingyi Peng; Zhichun Liu; Wenjie Zheng
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-11-16       Impact factor: 5.346

3.  Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.

Authors:  Jurgen Sota; Luca Cantarini; Antonio Vitale; Arianna Sgheri; Stefano Gentileschi; Valeria Caggiano; Viviana Gelardi; Bruno Frediani; Gian Marco Tosi; Claudia Fabiani
Journal:  Mediators Inflamm       Date:  2020-05-15       Impact factor: 4.711

4.  A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet's syndrome.

Authors:  Noe Horiguchi; Koju Kamoi; Shintaro Horie; Yuko Iwasaki; Hisako Kurozumi-Karube; Hiroshi Takase; Kyoko Ohno-Matsui
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

5.  Development and implementation of the AIDA International Registry for patients with Behçet's disease.

Authors:  Claudia Fabiani; Luca Cantarini; Antonio Vitale; Francesca Della Casa; Gaafar Ragab; Ibrahim A Almaghlouth; Giuseppe Lopalco; Rosa Maria Pereira; Silvana Guerriero; Marcello Govoni; Petros P Sfikakis; Roberto Giacomelli; Francesco Ciccia; Sara Monti; Piero Ruscitti; Matteo Piga; Claudia Lomater; Abdurrahman Tufan; Daniela Opris-Belinski; Giacomo Emmi; José Hernández-Rodríguez; Ali Şahin; Gian Domenico Sebastiani; Elena Bartoloni; Nurullah Akkoç; Özgül Soysal Gündüz; Marco Cattalini; Giovanni Conti; Gulen Hatemi; Armin Maier; Paola Parronchi; Emanuela Del Giudice; Sukran Erten; Antonella Insalaco; Francesca Li Gobbi; Maria Cristina Maggio; Farhad Shahram; Valeria Caggiano; Mohamed Tharwat Hegazy; Kazi Nur Asfina; Maria Morrone; Leandro L Prado; Rosanna Dammacco; Francesca Ruffilli; Aikaterini Arida; Luca Navarini; Ilenia Pantano; Lorenzo Cavagna; Alessandro Conforti; Alberto Cauli; Elena Maria Marucco; Hamit Kucuk; Ruxandra Ionescu; Irene Mattioli; Gerard Espinosa; Olga Araújo; Burak Karkaş; Claudia Canofari; Jurgen Sota; Ahmed Hatem Laymouna; Asma A Bedaiwi; Sergio Colella; Henrique Ayres M Giardini; Valeria Albano; Andrea Lo Monaco; George E Fragoulis; Riza Can Kardas; Virginia Berlengiero; Mohamed A Hussein; Francesca Ricci; Francesco La Torre; Donato Rigante; Ewa Więsik-Szewczyk; Micol Frassi; Stefano Gentileschi; Gian Marco Tosi; Marilia Ambiel Dagostin; Ayman Abdel-Monem Ahmed Mahmoud; Maria Tarsia; Giovanni Alessio; Rolando Cimaz; Teresa Giani; Carla Gaggiano; Florenzo Iannone; Paola Cipriani; Mariam Mourabi; Veronica Spedicato; Sara Barneschi; Emma Aragona; Alberto Balistreri; Bruno Frediani
Journal:  Intern Emerg Med       Date:  2022-07-14       Impact factor: 5.472

6.  Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Giacomo Emmi; Stefano Gentileschi; Carla Gaggiano; Luisa Ciarcia; Virginia Berlengiero; Mariam Mourabi; Nicola Ricco; Sara Barneschi; Irene Mattioli; Gian Marco Tosi; Bruno Frediani; Maria Tarsia; Gerardo di Scala; Antonio Vitale; Florenzo Iannone; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2021-04-09       Impact factor: 3.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.